GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Mach7 Technologies Ltd (ASX:M7T) » Definitions » EV-to-EBIT

Mach7 Technologies (ASX:M7T) EV-to-EBIT : -6.55 (As of May. 18, 2024)


View and export this data going back to 2005. Start your Free Trial

What is Mach7 Technologies EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Mach7 Technologies's Enterprise Value is A$141.18 Mil. Mach7 Technologies's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$-21.57 Mil. Therefore, Mach7 Technologies's EV-to-EBIT for today is -6.55.

The historical rank and industry rank for Mach7 Technologies's EV-to-EBIT or its related term are showing as below:

ASX:M7T' s EV-to-EBIT Range Over the Past 10 Years
Min: -381.72   Med: -3.25   Max: 1.04
Current: -6.56

During the past 13 years, the highest EV-to-EBIT of Mach7 Technologies was 1.04. The lowest was -381.72. And the median was -3.25.

ASX:M7T's EV-to-EBIT is ranked worse than
100% of 427 companies
in the Healthcare Providers & Services industry
Industry Median: 18.27 vs ASX:M7T: -6.56

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Mach7 Technologies's Enterprise Value for the quarter that ended in Dec. 2023 was A$168.88 Mil. Mach7 Technologies's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$-21.57 Mil. Mach7 Technologies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -12.77%.


Mach7 Technologies EV-to-EBIT Historical Data

The historical data trend for Mach7 Technologies's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mach7 Technologies EV-to-EBIT Chart

Mach7 Technologies Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -8.87 -294.92 -20.23 -14.75 -7.38

Mach7 Technologies Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -14.75 - -7.38 -

Competitive Comparison of Mach7 Technologies's EV-to-EBIT

For the Health Information Services subindustry, Mach7 Technologies's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mach7 Technologies's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Mach7 Technologies's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Mach7 Technologies's EV-to-EBIT falls into.



Mach7 Technologies EV-to-EBIT Calculation

Mach7 Technologies's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=141.178/-21.567
=-6.55

Mach7 Technologies's current Enterprise Value is A$141.18 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Mach7 Technologies's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$-21.57 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mach7 Technologies  (ASX:M7T) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Mach7 Technologies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=-21.567/168.88089
=-12.77 %

Mach7 Technologies's Enterprise Value for the quarter that ended in Dec. 2023 was A$168.88 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Mach7 Technologies's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$-21.57 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mach7 Technologies EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Mach7 Technologies's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Mach7 Technologies (ASX:M7T) Business Description

Traded in Other Exchanges
N/A
Address
120 Kimball Avenue, Suite 210, South Burlington, VT, USA, 05403
Mach7 Technologies Ltd is engaged in enterprise imaging data sharing, storage, and interoperability for healthcare enterprises globally. The principal activity of the Company is the development and commercialisation of medical imaging and data, management software solutions for global healthcare enterprises The company's operating segment includes Software licenses and Professional services. It generates maximum revenue from the Software licenses segment. Geographically, it derives a majority of its revenue from North America and also has a presence in the Middle East; Asia/Pacific and Europe, and other regions. The company's solutions include Management Studio; Diagnostic Studio; and Clinical Studio.

Mach7 Technologies (ASX:M7T) Headlines

No Headlines